Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Study ID
- NCT05904210
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SEVENFACT® — DRUGCoagulation Factor VIIa (Recombinant)
Study Details
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.
Key Dates
- First listed
- Jun 15, 2023
- Start date
- Nov 7, 2023
- Status verified
- Jun 2024
- Primary completion
- May 9, 2024
- Completion
- May 9, 2024
Study Design
- Enrollment
- 17 participants (actual)
Arms
- Arm: Patients treated by SEVENFACT®Patients that initiated treatment with SEVENFACT® in real-world clinical care in the USA will be eligible. Data from eligible patients' medical charts, bleeding diaries, and medication logs will be extracted from the time of initiation of SEVENFACT® treatment and for each bleeding episode and surgery or invasive procedure requiring treatment with SEVENFACT® or for prophylaxis, up until the data collection at the investigational site.
Primary Outcome Measure
SEVENFACT® effectiveness [ Time Frame: For all events which took place from Jan 1st, 2021 up to site opening in 2023 ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Luskin Orthopaedic Institute for Children | Los Angeles | California | 90007 | - |
| Valley Children's Hospital | Madera | California | 93636 | - |
| Children's healthcare of Atlanta | Atlanta | Georgia | 30322 | - |
| Mayo Clinic | Rochester | Minnesota | 55905 | - |
| SUNY Upstate Medical University, Pediatric Hematology/Oncology | Syracuse | New York | 13210 | - |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | - |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| The Gulf States Hemophilia & Thrombophilia Center | Houston | Texas | 77030 | - |
Find similar trials in Los Angeles, CA
By research site
Luskin Orthopaedic Institute for Children· Los Angeles, CAValley Children's Hospital· Madera, CAChildren's healthcare of Atlanta· Atlanta, GAMayo Clinic· Rochester, MNSUNY Upstate Medical University, Pediatric Hematology/Oncology· Syracuse, NYUniversity Hospitals Cleveland Medical Center· Cleveland, OH
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Little Rock, Arkansas
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded StudyEARLY_PHASE1 · Recruiting · University of Minnesota · Minneapolis, Minnesota
- A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or BPHASE3 · Recruiting · Sanofi · Los Angeles, California